Navigation Links
Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
Date:1/25/2013

DEERFIELD, Ill. and OSAKA, Japan, Jan. 25, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved NESINA (alogliptin) and the fixed-dose combination (FDC) therapies OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl) for the treatment of type 2 diabetes in adults as adjuncts to diet and exercise.

"Takeda is pleased with the FDA approval of NESINA, OSENI and KAZANO for the treatment of type 2 diabetes, a therapeutic category in which we have more than twenty years of clinical and patient experience," said Douglas Cole , president, Takeda Pharmaceuticals U.S.A., Inc. "Millions of people are affected by diabetes and, as a leader in the diabetes arena, Takeda is dedicated to working to advance patient care and helping to meet the needs of this growing patient population."

NESINA is a dipeptidyl peptidase-4 inhibitor (DPP-4i) that is designed to slow the inactivation of incretin hormones GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). OSENI, which combines alogliptin with pioglitazone, is the first product in the U.S. to include both a DPP-4i and a thiazolidinedione (TZD) in a single tablet. KAZANO combines alogliptin with metformin HCl, a widely used anti-diabetes medication, in a single tablet.

The most common adverse events (greater than or equal to 4%) reported with NESINA include nasopharyngitis, headache and upper respiratory tract infection. With regard to OSENI, common adverse events (greater than or equal to 4%) reported include nasopharyngitis, back pain and upper respiratory tract infection. Common adverse events (greater than or equal to 4%) re
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
2. Takedas Deerfield Campus Ranked Among Chicagos Top 100 Workplaces in 2012
3. Takeda Completes its Russian Pharmaceutical Manufacturing Facility
4. Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
5. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
6. Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil
7. IntelliCell BioSciences Receives Notice of Allowance for its US Patent for "Ultrasonic Cavitation of Adipose Tissue to Produce Stromal Vascular Fraction Regenerative Cells"
8. Zimmer Receives FDA Clearance for Revolutionary New Surgical Guidance Technology
9. American Capital Receives $60 Million From The Sale Of Lifoam Holdings And Generates An 11% Return On Its Investment
10. PrimeMail, Prime Therapeutics mail-service pharmacy, receives URAC Reaccreditation
11. Brolex C SAFE cesarean section safety device receives top scores, rated a MUST HAVE medical device for performing c/sections.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... QC , Nov. 28, 2014 /CNW Telbec/ - Ergoresearch ... and known under the « Équilibre, orthèses et ... Ended on September 30, 2014. All dollar amounts in the ... for the first quarter of fiscal year 2015 ended this ... by 2,1 % compared to revenues of $ 4 227 942 ...
(Date:11/28/2014)... , Nov. 28, 2014 According to MedlinePlus, ... the course of their lifetime. For many, these pains are ... that is caused by a variety of factors. For those ... may be the best option. While there are a variety ... performed by Seyed M. Rezaian , M.D., Ph.D., F.R.C.S., ...
(Date:11/28/2014)... 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... its wholly owned subsidiary, Valeant Pharmaceuticals International, will ... outstanding 6.875% Senior Notes due 2018, CUSIP Nos. ... 29, 2014 and has mailed an irrevocable notice ... approximately US$500 million aggregate principal amount of the ...
Breaking Medicine Technology:First Quarter Results fiscal year ended September 30, 2015 - Ergoresearch reports its results for the quarter ended September 30, 2014. 2First Quarter Results fiscal year ended September 30, 2015 - Ergoresearch reports its results for the quarter ended September 30, 2014. 3First Quarter Results fiscal year ended September 30, 2015 - Ergoresearch reports its results for the quarter ended September 30, 2014. 44 Advantages of Laser Back Surgery When Fixing a Herniated Disk 2Valeant Announces Redemption of US$445.0 Million Aggregate Principal Amount of its Outstanding 6.875% Senior Notes due 2018 2
... NEW YORK, Dec. 16, 2010 Teach For America ... their partnership to advance math and science education in ... Foundation pledged $1.8 million to increase the number of ... America,s teaching corps by 2013.  This new grant brings ...
... VILLAGE, Colo., Dec. 16, 2010 Astrum Hearing Inc., an ... in no way affiliated with Astrum Marketing Inc., also known ... Chapter 7 bankruptcy pending in the Middle District of Florida. ... of the "Sears Hearing By Astrum" centers. Astrum ...
Cached Medicine Technology:Teach For America and the Amgen Foundation Renew Partnership to Improve Math and Science Education in Urban and Rural Schools 2Teach For America and the Amgen Foundation Renew Partnership to Improve Math and Science Education in Urban and Rural Schools 3Astrum Hearing Inc. Is Not Affiliated with Astrum Hearing Aid Centers or Astrum Marketing 2
(Date:11/28/2014)... Albany, NewYork (PRWEB) November 29, 2014 ... market, followed by Europe. The U.S. market is highly ... and ongoing researches in different clinical institutes such as ... developed markets, the Asia-Pacific region is expected to show ... and Rest of the World are poised to grow ...
(Date:11/28/2014)... November 29, 2014 Somax Performance ... analyzing, measuring and improving sports performance, is pleased ... have surpassed 3,000,00 views. The Institute, which works ... communities, improves performance far beyond conventional coaching and ... and Microfiber Reduction. , Many viewers have praised ...
(Date:11/28/2014)... (PRWEB) November 29, 2014 ... Informatics has encouraged research in all the ... medicine, clinical decision support and population health ... integrates most recent innovation in machine learning, ... , View full report with full ...
(Date:11/28/2014)... 29, 2014 Lunadress.co.uk, one of the ... dresses, has recently released its fashionable white prom gowns. ... high quality and low price. The company provides a ... order, and free shipping for orders over 99 pounds. ... its professional sales representatives if needed. The kind experts ...
(Date:11/28/2014)... is a renowned women’s dress company. The company is ... for the global clients. Recently, iFitDress.com has announced its ... store. The new products are now provided at discounted ... sales manager of the company, the chic teal cocktail ... international market. , “We are happy to unveil ...
Breaking Medicine News(10 mins):Health News:Researchmoz : Global Radiopharmaceuticals/Nuclear Medicine Market Analysis - Trends & Forecast to 2020 2Health News:Researchmoz : Global Radiopharmaceuticals/Nuclear Medicine Market Analysis - Trends & Forecast to 2020 3Health News:Somax Sports Motion Analysis Videos Surpass 3,000,000 Views 2Health News:Somax Sports Motion Analysis Videos Surpass 3,000,000 Views 3Health News:Medical & Healthcare Analytics Market Report: Global Industry Size, Share, Trends, Growth and Forecast by Researchmoz.us 2Health News:LunaDress.co.uk: New White LunaDress Prom Gowns Online for Sale Now 2Health News:Discounted Teal Cocktail Dresses From Famous Dress Supplier iFitDress.com 2
... , INDIANAPOLIS -- In recognition of his significant contributions ... investigator Malaz Boustani, M.D., MPH, associate professor of medicine ... the 2012 American Geriatrics Society Outstanding Scientific Achievement for ... the American Geriatrics Society annual meeting in Seattle in ...
... mainstay of diagnostic medicine since the late 19th century, ... Nevertheless, blood derived from the human umbilical cord has ... information, according to Rolf Halden, a researcher at Arizona ... appearing in the journal Environmental Health Perspectives , ...
... been issued to Moffitt Cancer Center for a computerized system ... trial. The newly patented system matches the registered patient,s own ... patient-donated biological tissue or tumor samples to the molecular ... the molecular level, and does it quickly. The system promises ...
... the field of Physical Anthropology. She not only holds ... Republic, but she is also the Chair of the ... Department of Genetics, Physical Anthropology and Animal Physiology of ... out numerous pieces of work into nutritional habits, life ...
... genetic mutation that gives them a high risk of several ... are damaged can,t repair any errors that occur in our ... Journal of Clinical Oncology , confirmed the increased risk ... including colon, uterus, ovary, kidney, stomach, and bladder cancers. ...
... 12 (HealthDay News) -- A best friend can help children ... a best friend present during an unpleasant event has an ... co-author William Bukowski, a psychology professor and director of the ... Montreal. "If a child is alone when he or she ...
Cached Medicine News:Health News:Geriatrician from Regenstrief Institute and Indiana University honored 2Health News:Following a trail of blood: A new diagnostic tool comes of age 2Health News:Following a trail of blood: A new diagnostic tool comes of age 3Health News:New Moffitt Cancer Center patent promises to accelerate cancer trials 2Health News:Analyzing the causes of obesity in the Romani ethnic group 2Health News:Analyzing the causes of obesity in the Romani ethnic group 3Health News:New analysis provides clearer picture of cancer risks associated with Lynch syndrome 2Health News:Best Friend Benefits Child's Mind, Body, Study Finds 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: